Isabelle Baillet

VP Finance at Aptissen SA

Isabelle Baillet serves as the VP Finance at Aptissen SA, where responsibilities include leading the finance function and securing a new institutional financing of 5 million CHF to support organic growth for a medical device company focused on injectable Hyaluronic Acid for osteoarthritis. Prior experience includes roles at Etihad Airways as Head of Finance for Central & Western Europe, overseeing a financial setup of $400 million, and managing the Finance Manager position in Switzerland. Isabelle has also held the position of Corporate Finance Senior Manager at Genexion SA, responsible for finance and administration across 10 affiliates, and worked as a Financial Analyst at LA CROISSANTERIE, contributing to budget and profitability analyses. Early in their career, Isabelle co-founded Eq'Idées, a startup specializing in horseback riding equipment, and successfully raised €600,000 through a business plan. Educational background includes a Master’s degree from IPAG Business School and evening classes at Harvard Business School focused on Comparative Economic Systems and Capital Markets.

Location

Geneva, Switzerland

Links


Org chart

No direct reports

Teams


Offices


Aptissen SA

Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors'​ network among more than 90 countries including Europe, South America, Canada, Middle East and Asia. Aptissen's team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid to provide fast pain relief.


Employees

11-50

Links